The Effects of Myrtle (Myrtus communis ) and Clindamycin Topical Solution in the Treatment of Mild to Moderate Acne Vulgaris: A Comparative Split-Face Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Although Acne vulgaris is a chronic skin disease, which its standard treatment causes therapeutic limitations and some common adverse effects, medicinal plants can be effective in treatment with low adverse effects as combination therapy. Myrtle (Myrtus Communis) has some beneficial properties, which has been administered topically and orally for some skin diseases in Persian medicine. This study aimed to compare the effi-cacy and safety of Myrtle formula and 1% clindamycin topical solution. Methods: This was a split-face clinical trial that was done on 55 patients with mild to mod-erate acne vulgaris for 16 weeks. The patients received topical Myrtle solution to the rightside of the face (group 1) and clindamycin solution to the left side (group 2) twice daily for12 weeks. All participants were examined for the acne severity index (ASI) and total acne lesions counting (TLC) at certain times during the study. Then, they stopped using them for four weeks. They also did not take the drug in the final four weeks of the study. Results: Forty-eight patients completed the study for 16 weeks; 40 (83.2%) patients were female and the rest of them were male. The mean age and standard deviation were 25.62 ± 7.62 years. After 12 weeks, the percentage changes of comedones, inflammatory le-sions, ASI and TLC were significantly reduced in both groups (p < 0.001). The percentage change of inflammatory lesions and ASI decrease was significantly higher in the group 1 (p = 0.03). There was no significant difference in the incidence of side effects between the two groups. There was a more significant decrease in sebum percentage change in the group 1 (p = 0.003). Conclusion: Myrtle lotion was effective and safe for the treatment of mild to moderate acne vulgaris.
Abstract
Objectives: Although Acne vulgaris is a chronic skin disease, which its standard treatment causes therapeutic limitations and some common adverse effects, medicinal plants can be effective in treatment with low adverse effects as combination therapy. Myrtle (Myrtus Communis) has some beneficial properties, which has been administered topically and orally for some skin diseases in Persian medicine. This study aimed to compare the effi-cacy and safety of Myrtle formula and 1% clindamycin topical solution. Methods: This was a split-face clinical trial that was done on 55 patients with mild to mod-erate acne vulgaris for 16 weeks. The patients received topical Myrtle solution to the rightside of the face (group 1) and clindamycin solution to the left side (group 2) twice daily for12 weeks. All participants were examined for the acne severity index (ASI) and total acne lesions counting (TLC) at certain times during the study. Then, they stopped using them for four weeks. They also did not take the drug in the final four weeks of the study. Results: Forty-eight patients completed the study for 16 weeks; 40 (83.2%) patients were female and the rest of them were male. The mean age and standard deviation were 25.62 ± 7.62 years. After 12 weeks, the percentage changes of comedones, inflammatory le-sions, ASI and TLC were significantly reduced in both groups (p < 0.001). The percentage change of inflammatory lesions and ASI decrease was significantly higher in the group 1 (p = 0.03). There was no significant difference in the incidence of side effects between the two groups. There was a more significant decrease in sebum percentage change in the group 1 (p = 0.003). Conclusion: Myrtle lotion was effective and safe for the treatment of mild to moderate acne vulgaris.
참고문헌 (31)
- Wolkenstein P, "Acne prevalence and associations with lifestyle : a cross-sectional online survey of adolescents", young adults in 7 European countries, 2018, pp.32(2), 298~306
- Bagatin E, "Acne vulgaris : prevalence and clinical forms in adolescents from São Paulo, Brazil", An Bras Dermatol, 89(3), pp.428~435 (2014)
- Knutsen-Larson S, "Acne vulgaris : pathogenesis, treatment, and needs assessment", Dermatol Clin, 30(1), pp.99~106 (2012)
- Zaenglein AL, "Guidelines of care for the management of acne vulgaris", J Am Acad Dermatol, 74(5), pp.945~973.e33 (2016)
- Sevimli Dikicier B, "Topical treatment of acne vulgaris : efficiency, side effects, and adherence rate", J Int Med Res, 47(7), pp.2987~2992 (2019)
- Azimi H, "A review of phytotherapy of acne vulgaris : perspective of new pharmacological treatments", Fitoterapia, 83(8), pp.1306~1317 (2012)
- V. K. Ghosh, "Different approaches of alternative medicines in acne vulgaris treatment", Oriental Pharmacy and Experimental Medicine, 11(1), pp.1~9 (2011), 융합한의과학연구소
- Avicenna, "Canon of medicine", pp.1426~ (2005), Dar Ehiaee Toras e Alarabi
- Fiorini-Puybaret C, "Pharmacological properties of Myrtacine® and its potential value in acne treatment", Planta Med, 77(14), pp.1582~1589 (2011)
- Feuillolay C, "A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris", Phytomedicine, 23(3), pp.307~315 (2016)
- Kim KY, "Effects of the myrtle essential oil on the acne skin-clinical trials for Korean women", Biomed Dermatol, 2(1), pp.28~ (2018)
- Afzali BM, "Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris : a randomized controlled trial", J Dermatolog Treat, 23(1), pp.21~25 (2012)
- Masterson KN, "Acne basics: pathophysiology, assessment, and standard treatment options", J Dermatol Nurses Assoc, 10(1S), pp.S2~S10 (2018)
- Williams HC, "Acne vulgaris", Lancet, 379(9813), pp.361~372 (2012)
- Arican O, "Oxidative stress in patients with acne vulgaris", Mediators Inflamm, 2005(6), pp.380~384 (2005)
- Cunliffe WJ, "Comedogenesis : some new aetiological, clinical and therapeutic strategies", Br J Dermatol, 142(6), pp.1084~1091 (2000)
- Leyden JJ, "Current issues in antimicrobial therapy for the treatment of acne", J Eur Acad Dermatol Venereol, 15(Suppl 3), pp.51~55 (2001)
- Owlia P, "Antimicrobial characteristics of some herbal oils on Pseudomonas aeruginosa with special reference to their chemical compositions", Iran J Pharm Res, 8(2), pp.107~114 (2009)
- Djenane D, "Chemical composition and antimicrobial effects of essential oils of Eucalyptus globulus, Myrtus communis and Satureja hortensis against Escherichia coli O157 : H7 and Staphylococcus aureus in minced beef", Food Sci Technol Int, 17(6), pp.505~515 (2011)
- Akin M, "Antibacterial activity and composition of the essential oils of Eucalyptus camaldulensis Dehn. and Myrtus communis L. growing in Northern Cyprus", Afr J Biotechnol, 9(4), pp.531~535 (2010)
- Hamdy AA, "In-vitro evaluation of certain Egyptian traditional medicinal plants against Propionibacterium acnes", S Afr J Bot, 109, pp.90~95 (2017)
- Sinha P, "New perspectives on antiacne plant drugs : contribution to modern therapeutics", Biomed Res Int, 2014, pp.301304~ (2014)
- Alipour G, "Review of pharmacological effects of Myrtus communis L. and its active constituents", Phytother Res, 28(8), pp.1125~1136 (2014)
- Feisst C, "Identification of molecular targets of the oligomeric nonprenylated acylphloroglucinols from Myrtus communis and their implication as antiinflammatory compounds", J Pharmacol Exp Ther, 315(1), pp.389~396 (2005)
- Jeremy AH, "Inflammatory events are involved in acne lesion initiation", J Invest Dermatol, 121(1), pp.20~27 (2003)
- Pratibha N, "Screening for antioxidant and antibacterial potential of common medicinal plants in the treatment of acne", Int J Drug Dev Res, 4(1), pp.65~71 (2012)
- Amensour M, "Total phenolic content and antioxidant activity of myrtle(Myrtus communis)extracts", Nat Prod Commun, 4(6), pp.819~824 (2009)
- Romani A, "Evaluation of antioxidant effect of different extracts of Myrtus communis L", Free Radic Res, 38(1), pp.97~103 (2004)
- Hennia A, "Antioxidant activity of Myrtus communis L. and Myrtus nivellei Batt. & Trab. Extracts:a brief review", Medicines (Basel), 5(3), pp.89~ (2018)
- Veraldi S, "Efficacy and tolerability of topical 0.2% Myrtacine® and 4% vitamin PP for prevention and treatment of retinoid dermatitis in patients with mild to moderate acne", G Ital Dermatol Venereol, 147(5), pp.491~497 (2012)
- Pécastaings S, "Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine ®", J Eur Acad Dermatol Venereol, 32(Suppl 2), pp.15~23 (2018)